Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak
- PMID: 32503855
- DOI: 10.1136/annrheumdis-2020-217957
Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak
Keywords: antirheumatic agents; cytokines; familial Mediterranean fever.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.
-
COVID-19 infection in a patient with FMF: does colchicine have a protective effect?Ann Rheum Dis. 2021 Mar;80(3):e39. doi: 10.1136/annrheumdis-2020-217882. Epub 2020 Jun 5. Ann Rheum Dis. 2021. PMID: 32503853 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical